Lu Rao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lu Rao has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Arne Gennerich
Department of Biochemistry and Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461
21 shared publications - Hernando Sosa
Department of Biochemistry and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, USA
6 shared publications - Ana B. Asenjo
Department of Biochemistry and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, USA
4 shared publications - Florian Berger
Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, Utrecht, the Netherlands
4 shared publications - Richard J. McKenney
Department of Molecular and Cellular Biology, University of California Davis, Davis, USA
4 shared publications - Abhipsa Shatarupa
Department of Biochemistry and Gruss‐Lipper Biophotonics Center Albert Einstein College of Medicine Bronx New York USA
3 shared publications
Latest Publications
- Open Access
Integrating Single-Molecule Variant Phenotyping with Clinical Features Predicts Outcomes in KIF1A-Associated Neurological Disorder
Rare monogenic diseases lack scalable prognostic frameworks, leaving patients and families without guidance after molecular diagnosis. Using KIF1A-associated neurological disorder (KAND) as a model system, we integrated single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients. Vineland Adaptive Behavior Scales (VABS) Adaptive Behavior Composite (ABC) and Growth Scales identified two divergent trajectories emerging after age 10: a stable group and a declining group characterized by seizures, abnormal EEGs, and optic nerve atrophy. A framework combining biophysical parameters, computational pathogenicity scores, and clinical variables classified patients as stable versus declining with AUC 0.834 and predicted VABS ABC scores with R² = 0.484 under leave-one-out cross-validation. For newly identified KIF1A variants, this approach offers a prognostic tool and a stratification strategy for clinical trials. Because kinesin motor function is mechanistically conserved, the framework may generalize to other kinesinopathies and to monogenic disorders amenable to quantitative functional assays.
Open AccessIntegrating Single-Molecule Variant Phenotyping with Clinical Features Predicts Outcomes in KIF1A-Associated Neurological Disorder
Rare monogenic diseases lack scalable prognostic frameworks, leaving patients and families without guidance after molecular diagnosis. Using KIF1A-associated neurological disorder (KAND) as a model system, we integrated single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients. Vineland Adaptive Behavior Scales (VABS) Adaptive Behavior Composite (ABC) and Growth Scales identified two divergent trajectories emerging after age 10: a stable group and a declining group characterized by seizures, abnormal EEGs, and optic nerve atrophy. A framework combining biophysical parameters, computational pathogenicity scores, and clinical variables classified patients as stable versus declining with AUC 0.834 and predicted VABS ABC scores with R² = 0.484 under leave-one-out cross-validation. For newly identified KIF1A variants, this approach offers a prognostic tool and a stratification strategy for clinical trials. Because kinesin motor function is mechanistically conserved, the framework may generalize to other kinesinopathies and to monogenic disorders amenable to quantitative functional assays.
- 11 June 2026
- Published by Wiley in Cytoskeleton
Beyond Binding Affinity: How a Conformation‐Specific Salt Bridge Tunes KIF1A Mechanochemistry
Mutations at KIF1A residue R350 are linked to hereditary spastic paraplegia type 30 (SPG30), part of the spectrum of KIF1A‐associated neurological disorders (KAND). Recent high‐resolution cryo‐EM structures of the KIF1A R350G and R350W mutants bound to microtubules in both nucleotide‐free (apo) and AMP‐PNP–bound states revealed a salt bridge between KIF1A R350 and α‐tubulin E415 that forms specifically in the open motor domain conformation and is abolished by both substitutions. Single‐molecule motility assays further showed that disruption of this conformation‐dependent electrostatic interaction increases motor velocity while reducing processivity and microtubule affinity in the apo state. These findings identify a previously unrecognized mechanism regulating KIF1A motility and highlight how subtle changes in motor mechanochemistry can contribute to KAND pathology.
- 11 June 2026
- Published by Wiley in Cytoskeleton
Beyond Binding Affinity: How a Conformation‐Specific Salt Bridge Tunes KIF1A Mechanochemistry
Mutations at KIF1A residue R350 are linked to hereditary spastic paraplegia type 30 (SPG30), part of the spectrum of KIF1A‐associated neurological disorders (KAND). Recent high‐resolution cryo‐EM structures of the KIF1A R350G and R350W mutants bound to microtubules in both nucleotide‐free (apo) and AMP‐PNP–bound states revealed a salt bridge between KIF1A R350 and α‐tubulin E415 that forms specifically in the open motor domain conformation and is abolished by both substitutions. Single‐molecule motility assays further showed that disruption of this conformation‐dependent electrostatic interaction increases motor velocity while reducing processivity and microtubule affinity in the apo state. These findings identify a previously unrecognized mechanism regulating KIF1A motility and highlight how subtle changes in motor mechanochemistry can contribute to KAND pathology.
- Open Access
The P3018S disease variant reveals how dynein's trailing motor sets ensemble velocity.
Mutations in the cytoplasmic dynein heavy chain (DYNC1H1) underlie a range of neurodevelopmental disorders yet how individual variants perturb dynein function remains poorly understood. We characterize the disease-associated P3018S mutation, located in the AAA4 module and within the Lis1-interacting region of the motor. Dynein-dynactin-BicD2 (DDB) complexes containing P3018S dynein move at half the wild-type velocity and generate reduced stall forces but retain the ability to assume the inhibitory phi conformation that Lis1 suppresses, respond to Lis1, and assemble into higher-order force-generating states. Several Schizosaccharomyces species, which lack Lis1, naturally encode a serine at this position, suggesting evolutionary relevance for dynein activation. Using mixed wild-type-mutant assemblies, we find that the dynein occupying the trailing position on dynactin dictates ensemble velocity, and that the leading dynein's LIC enhances trailing-motor velocity by ~130%, revealing a mechanism for leading-to-trailing motor stimulation within multi-dynein assemblies.
Open AccessThe P3018S disease variant reveals how dynein's trailing motor sets ensemble velocity.
Mutations in the cytoplasmic dynein heavy chain (DYNC1H1) underlie a range of neurodevelopmental disorders yet how individual variants perturb dynein function remains poorly understood. We characterize the disease-associated P3018S mutation, located in the AAA4 module and within the Lis1-interacting region of the motor. Dynein-dynactin-BicD2 (DDB) complexes containing P3018S dynein move at half the wild-type velocity and generate reduced stall forces but retain the ability to assume the inhibitory phi conformation that Lis1 suppresses, respond to Lis1, and assemble into higher-order force-generating states. Several Schizosaccharomyces species, which lack Lis1, naturally encode a serine at this position, suggesting evolutionary relevance for dynein activation. Using mixed wild-type-mutant assemblies, we find that the dynein occupying the trailing position on dynactin dictates ensemble velocity, and that the leading dynein's LIC enhances trailing-motor velocity by ~130%, revealing a mechanism for leading-to-trailing motor stimulation within multi-dynein assemblies.
- Open Access
- 31 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Pathogenic KIF1A R350 mutations disrupt a conserved and conformation-dependent kinesin-tubulin salt bridge
Pathogenic variants in the motor domain of the kinesin-3 motor protein KIF1A cause a range of neurodevelopmental and neurodegenerative conditions collectively termed KIF1A-associated neurological disorder (KAND). Among these, mutations at residue R350 are linked to hereditary spastic paraplegia and altered motor function. Yet, the structural basis for their pathogenicity remains unclear. Here, we present high-resolution cryo-electron microscopy (cryo-EM) structures of KIF1A R350G and R350W bound to microtubules in both the apo and AMP-PNP–bound states. We identify a salt bridge between KIF1A residue R350 and α-tubulin E415 that forms only in the open conformation of the motor domain and is disrupted in both mutants. The loss of this electrostatic interaction correlates with increased velocity, reduced processivity, and decreased microtubule affinity in the open, apo conformation, as demonstrated by single-molecule assays. Our results reveal an electrostatic interaction at the motor–microtubule interface that regulates KIF1A’s motility behavior.
- 31 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPathogenic KIF1A R350 mutations disrupt a conserved and conformation-dependent kinesin-tubulin salt bridge
Pathogenic variants in the motor domain of the kinesin-3 motor protein KIF1A cause a range of neurodevelopmental and neurodegenerative conditions collectively termed KIF1A-associated neurological disorder (KAND). Among these, mutations at residue R350 are linked to hereditary spastic paraplegia and altered motor function. Yet, the structural basis for their pathogenicity remains unclear. Here, we present high-resolution cryo-electron microscopy (cryo-EM) structures of KIF1A R350G and R350W bound to microtubules in both the apo and AMP-PNP–bound states. We identify a salt bridge between KIF1A residue R350 and α-tubulin E415 that forms only in the open conformation of the motor domain and is disrupted in both mutants. The loss of this electrostatic interaction correlates with increased velocity, reduced processivity, and decreased microtubule affinity in the open, apo conformation, as demonstrated by single-molecule assays. Our results reveal an electrostatic interaction at the motor–microtubule interface that regulates KIF1A’s motility behavior.
- Open Access
- 2 March 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (5) , 1088
Publisher Correction: Adaptor-mediated recruitment of three dyneins to dynactin enhances force generation
- 2 March 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (5) , 1088
Open AccessPublisher Correction: Adaptor-mediated recruitment of three dyneins to dynactin enhances force generation
- Open Access
- 16 February 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (3) , 480-491
Adaptor-mediated recruitment of three dyneins to dynactin enhances force generation
Cytoplasmic dynein is an essential microtubule motor protein that powers organelle transport and mitotic spindle assembly. Its activity depends on dynein–dynactin–cargo adaptor complexes, such as dynein–dynactin–BicD2, which typically function with two dynein motors. We show that mechanical tension recruits a third dynein motor via an auxiliary BicD2 adaptor binding the light intermediate chain of the third dynein, stabilizing multidynein assemblies and enhancing force generation. Lis1 prevents dynein from transitioning into a force-limiting phi-like conformation, allowing single-dynein dynein–dynactin–BicD2 to sustain forces up to approximately 4.5 pN, whereas force generation often ends at about 2.5 pN without Lis1. Complexes with two or three dyneins generate 7 pN and 9 pN, respectively, consistent with a staggered motor arrangement that enhances collective output. Under load, dynein–dynactin–BicD2 primarily takes 8-nm steps, challenging existing dynein coordination models. These findings reveal adaptive mechanisms that enable robust intracellular transport under varying mechanical demands.
- 16 February 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (3) , 480-491
Open AccessAdaptor-mediated recruitment of three dyneins to dynactin enhances force generation
Cytoplasmic dynein is an essential microtubule motor protein that powers organelle transport and mitotic spindle assembly. Its activity depends on dynein–dynactin–cargo adaptor complexes, such as dynein–dynactin–BicD2, which typically function with two dynein motors. We show that mechanical tension recruits a third dynein motor via an auxiliary BicD2 adaptor binding the light intermediate chain of the third dynein, stabilizing multidynein assemblies and enhancing force generation. Lis1 prevents dynein from transitioning into a force-limiting phi-like conformation, allowing single-dynein dynein–dynactin–BicD2 to sustain forces up to approximately 4.5 pN, whereas force generation often ends at about 2.5 pN without Lis1. Complexes with two or three dyneins generate 7 pN and 9 pN, respectively, consistent with a staggered motor arrangement that enhances collective output. Under load, dynein–dynactin–BicD2 primarily takes 8-nm steps, challenging existing dynein coordination models. These findings reveal adaptive mechanisms that enable robust intracellular transport under varying mechanical demands.
- Open Access
Pathogenic KIF1A R350 Variants Disrupt A Conserved Kinesin-Tubulin Salt Bridge
Pathogenic variants in the motor domain of the kinesin-3 motor protein KIF1A cause a range of neurodevelopmental and neurodegenerative conditions collectively termed KIF1A-associated neurological disorder (KAND). Among these, mutations at residue R350 are linked to hereditary spastic paraplegia and altered motor function. Yet, the structural basis for their pathogeny remains unclear. Here, we present high-resolution cryo-electron microscopy (cryo-EM) structures of KIF1A R350G and R350W bound to microtubules in both the apo and AMP-PNP-bound states. We identify a previously unrecognized salt bridge between KIF1A residue R350 and α-tubulin E415 that is disrupted in both mutants. This loss of electrostatic interaction correlates with increased velocity and reduced processivity, as demonstrated by single-molecule assays. Our results reveal a conserved electrostatic interaction at the motor–microtubule interface that regulates KIF1A’s motility behavior.
Open AccessPathogenic KIF1A R350 Variants Disrupt A Conserved Kinesin-Tubulin Salt Bridge
Pathogenic variants in the motor domain of the kinesin-3 motor protein KIF1A cause a range of neurodevelopmental and neurodegenerative conditions collectively termed KIF1A-associated neurological disorder (KAND). Among these, mutations at residue R350 are linked to hereditary spastic paraplegia and altered motor function. Yet, the structural basis for their pathogeny remains unclear. Here, we present high-resolution cryo-electron microscopy (cryo-EM) structures of KIF1A R350G and R350W bound to microtubules in both the apo and AMP-PNP-bound states. We identify a previously unrecognized salt bridge between KIF1A residue R350 and α-tubulin E415 that is disrupted in both mutants. This loss of electrostatic interaction correlates with increased velocity and reduced processivity, as demonstrated by single-molecule assays. Our results reveal a conserved electrostatic interaction at the motor–microtubule interface that regulates KIF1A’s motility behavior.
- Open Access
Enhanced axonal transport in large vertebrates: KIF5A adaptations in giraffes and pythons
SUMMARY: Efficient axonal transport is essential for neuronal function, particularly in species with exceptionally long axons. The Kinesin-1 motor protein KIF5A plays a key role in this process, but whether and how it adapts to the transport demands of large vertebrates remains unclear. Here, we show that KIF5A from giraffes (GcKIF5A) and pythons (PbKIF5A), moves 25% faster than its mouse counterpart (MmKIF5A) on neuronal microtubules in vitro and within axons of cultured mouse hippocampal neurons. This enhanced velocity, driven by three unique amino acid substitutions (R114Q, S155A and Y309F), facilitates long-distance transport in these species and represents a case of convergent evolution. Our structural analysis reveals that accelerated ADP release underlies the increased speed of GcKIF5A. Despite exhibiting a reduced force generation, GcKIF5A maintains efficient cargo transport under load. Furthermore, GcKIF5A exerts less drag in mixed-motor environments, an adaptation particularly beneficial for multiple motor-driven long-distance axonal transport. These findings reveal that KIF5A has evolved specific adaptations to facilitate efficient axonal transport in large vertebrates, highlighting the evolutionary plasticity of kinesin motors.
Open AccessEnhanced axonal transport in large vertebrates: KIF5A adaptations in giraffes and pythons
SUMMARY: Efficient axonal transport is essential for neuronal function, particularly in species with exceptionally long axons. The Kinesin-1 motor protein KIF5A plays a key role in this process, but whether and how it adapts to the transport demands of large vertebrates remains unclear. Here, we show that KIF5A from giraffes (GcKIF5A) and pythons (PbKIF5A), moves 25% faster than its mouse counterpart (MmKIF5A) on neuronal microtubules in vitro and within axons of cultured mouse hippocampal neurons. This enhanced velocity, driven by three unique amino acid substitutions (R114Q, S155A and Y309F), facilitates long-distance transport in these species and represents a case of convergent evolution. Our structural analysis reveals that accelerated ADP release underlies the increased speed of GcKIF5A. Despite exhibiting a reduced force generation, GcKIF5A maintains efficient cargo transport under load. Furthermore, GcKIF5A exerts less drag in mixed-motor environments, an adaptation particularly beneficial for multiple motor-driven long-distance axonal transport. These findings reveal that KIF5A has evolved specific adaptations to facilitate efficient axonal transport in large vertebrates, highlighting the evolutionary plasticity of kinesin motors.
- Open Access
- 2 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (5) , 656
Distinct Clinical Phenotypes in KIF1A-Associated Neurological Disorders Result from Different Amino Acid Substitutions at the Same Residue in KIF1A
KIF1A is a neuron-specific kinesin motor responsible for intracellular transport along axons. Pathogenic KIF1A mutations cause KIF1A-associated neurological disorders (KAND), a spectrum of severe neurodevelopmental and neurodegenerative conditions. While individual KIF1A mutations have been studied, how different substitutions at the same residue affect motor function and disease progression remains unclear. Here, we systematically examine the molecular and clinical consequences of mutations at three key motor domain residues—R216, R254, and R307—using single-molecule motility assays and genotype–phenotype associations. We find that different substitutions at the same residue produce distinct molecular phenotypes, and that homodimeric mutant motor properties correlate with developmental outcomes. In addition, we present the first analysis of heterodimeric KIF1A motors—mimicking the heterozygous context in patients—and demonstrate that while heterodimers retain substantial motility, their properties are less predictive of clinical severity than homodimers. These results highlight the finely tuned mechanochemical properties of KIF1A and suggest that dysfunctional homodimers may disproportionately drive the diverse clinical phenotypes observed in KAND. By establishing residue-specific genotype–phenotype relationships, this work provides fundamental insights into KAND pathogenesis and informs targeted therapeutic strategies.
- 2 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (5) , 656
Open AccessDistinct Clinical Phenotypes in KIF1A-Associated Neurological Disorders Result from Different Amino Acid Substitutions at the Same Residue in KIF1A
KIF1A is a neuron-specific kinesin motor responsible for intracellular transport along axons. Pathogenic KIF1A mutations cause KIF1A-associated neurological disorders (KAND), a spectrum of severe neurodevelopmental and neurodegenerative conditions. While individual KIF1A mutations have been studied, how different substitutions at the same residue affect motor function and disease progression remains unclear. Here, we systematically examine the molecular and clinical consequences of mutations at three key motor domain residues—R216, R254, and R307—using single-molecule motility assays and genotype–phenotype associations. We find that different substitutions at the same residue produce distinct molecular phenotypes, and that homodimeric mutant motor properties correlate with developmental outcomes. In addition, we present the first analysis of heterodimeric KIF1A motors—mimicking the heterozygous context in patients—and demonstrate that while heterodimers retain substantial motility, their properties are less predictive of clinical severity than homodimers. These results highlight the finely tuned mechanochemical properties of KIF1A and suggest that dysfunctional homodimers may disproportionately drive the diverse clinical phenotypes observed in KAND. By establishing residue-specific genotype–phenotype relationships, this work provides fundamental insights into KAND pathogenesis and informs targeted therapeutic strategies.
- Open Access
Distinct Clinical Phenotypes in KIF1A-Associated Neurological Disorders Result from Different Amino Acid Substitutions at the Same Residue in KIF1A
KIF1A is a neuron-specific kinesin motor responsible for intracellular transport along axons. Pathogenic KIF1A mutations cause KIF1A-associated neurological disorders (KAND), a spectrum of severe neurodevelopmental and neurodegenerative conditions. While individual KIF1A mutations have been studied, how different substitutions at the same residue affect motor function and disease progression remains unclear. Here, we systematically examine the molecular and clinical consequences of mutations at three key motor domain residues—R216, R254, and R307—using single-molecule motility assays and genotype-phenotype associations. Our findings reveal that mutations at R216 and R254 produce residue-specific effects, with some substitutions partially retaining function, whereas R307 mutations universally abolish motility, likely due to its critical role in microtubule binding. Mutant motor properties correlate with developmental outcomes, with R307 mutations linked to the most sever impairments. These results demonstrate that even single-residue substitutions can lead to distinct molecular and clinical phenotypes, highlighting the finely tuned mechanochemical properties of KIF1A. By establishing residue-specific genotype-phenotype relationships, this work provides fundamental insights into KAND pathogenesis and informs targeted therapeutic strategies.
Open AccessDistinct Clinical Phenotypes in KIF1A-Associated Neurological Disorders Result from Different Amino Acid Substitutions at the Same Residue in KIF1A
KIF1A is a neuron-specific kinesin motor responsible for intracellular transport along axons. Pathogenic KIF1A mutations cause KIF1A-associated neurological disorders (KAND), a spectrum of severe neurodevelopmental and neurodegenerative conditions. While individual KIF1A mutations have been studied, how different substitutions at the same residue affect motor function and disease progression remains unclear. Here, we systematically examine the molecular and clinical consequences of mutations at three key motor domain residues—R216, R254, and R307—using single-molecule motility assays and genotype-phenotype associations. Our findings reveal that mutations at R216 and R254 produce residue-specific effects, with some substitutions partially retaining function, whereas R307 mutations universally abolish motility, likely due to its critical role in microtubule binding. Mutant motor properties correlate with developmental outcomes, with R307 mutations linked to the most sever impairments. These results demonstrate that even single-residue substitutions can lead to distinct molecular and clinical phenotypes, highlighting the finely tuned mechanochemical properties of KIF1A. By establishing residue-specific genotype-phenotype relationships, this work provides fundamental insights into KAND pathogenesis and informs targeted therapeutic strategies.